Author Topic: (Abst.) Early treatment delays long-term disability accrual in RRMS  (Read 38 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
Experts are saying more and more often that the disease-modifying drugs work best when prescribed soon after the onset of MS. On the other hand, doctors hesitate to diagnose MS because it is such a difficult disease to diagnose, and so many wait until time passes and they will have had a chance to observe the patient over time.  Rushing to prescribe a DMT for someone who has a disorder that isn't MS seems very unwise.


This abstract is from Multiple Sclerosis Journal (April 26, 2021), "Early treatment delays long-term disability accrual in RRMS:  Results from the BMSD Network":


https://journals.sagepub.com/doi/abs/10.1177/13524585211010128
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics